v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2024
Jun. 30, 2023
Revenue            
Revenues $ 3,160,480 $ 5,223,242 $ 11,522,487 $ 20,960,812 $ 26,000,652 $ 36,441,695
Cost of Revenue 1,601,374 3,955,559 4,059,207 9,696,598 13,176,073 15,421,715
Gross profit 1,559,106 1,267,683 7,463,280 11,264,214 12,824,579 21,019,980
Operating expenses            
Sales and marketing 1,039,299 1,275,974 3,030,687 4,578,950 5,989,727 6,067,392
Distribution costs 990,049 2,061,469 3,722,196 6,693,573 8,611,702 9,465,149
General and administrative expenses 2,642,654 1,790,611 5,558,934 4,953,300 6,771,937 6,875,575
Unrealized (gain) loss on digital assets 5,268 0 5,268 0    
Share-based compensation 521,353 212,758 695,229 965,229 1,169,843 3,664,538
Amortization of acquired intangible assets 19,191 658,858 57,571 1,976,574 2,410,431 2,568,502
Depreciation 198,519 306,185 658,986 901,521 1,268,355 913,246
Lease impairment (gain on settlement) (269,994) 0 (269,994) 289,969 3,159,477 1,015,997
Impairment of long-lived asset - building         336,434 0
Loss on the sale / abandonment of assets in relocation         569,195 0
Impairment of intangible assets and goodwill         7,869,425 3,746,301
Lease impairment, Delray Beach facility         289,969 0
Total operating expenses 5,146,339 6,305,855 13,458,877 20,359,116 35,287,018 33,300,703
Loss from operations (3,587,233) (5,038,172) (5,995,597) (9,094,902) (22,462,439) (12,280,723)
Other income (expenses), net            
Change in derivative liability         0 1,770
Interest (expense) income, net (245,103) (736,551) (763,626) (2,612,359) (3,124,723) (4,716,274)
Other 676 (10,376) 676 (30,063) (16,443) 38,344
Other income (expense), net (244,427) (746,927) (762,950) (2,642,422) (3,141,166) (4,676,160)
Loss on operations before income tax (3,831,660) (5,785,099) (6,758,547) (11,737,324) (25,603,605) (16,956,883)
Income tax benefit         332,101 3,049,293
Total income tax expense benefit 0 1,501,595 0 2,668,769 332,101 3,049,293
Net income (loss) from continuing operations (3,831,660) (4,283,504) (6,758,547) (9,068,555) (25,271,504) (13,907,590)
Gain (loss) from the sale of:            
Infusionz and select assets         0 (2,212,542)
Interactive Offers 0 (103,263) 0 237,670 237,670 0
Gain Loss From The Sale Of Vita Medica         1,948,538 0
E-core         (1,737,326) 0
Gain (loss) from the sale of total 0 (103,263) 0 237,670 448,882 (2,212,542)
Income (loss) on discontinued operations            
Income (loss) on discontinued operations Infuisionz         71,976 (338,418)
Income (loss) on discontinued operations Interactive offers 0 0 0 (193,040) (187,003) (1,729,636)
VitaMedica 0 81,978 0 239,908 213,636 (382,449)
E-core 0 186,177 0 871,098 1,065,575 1,080,379
Income (loss) income from discontinued operations 0 268,155 0 917,966 1,164,184 (1,370,124)
Net loss attributable to non-controlling interest         0 559,967
Net income (loss) attributable to Upexi, Inc. $ (3,831,660) $ (4,118,612) $ (6,758,547) $ (7,912,919) $ (23,658,438) $ (16,930,289)
Basic income (loss) per share:            
Income (loss) per shares from continuing operations $ (2.87) $ (4.19) $ (5.92) $ (8.75) $ (24.60) $ (15.56)
(Loss) income per shares from discontinued operations 0 0.26 0 0.89 1.13 (1.53)
Total income (loss) per share attributable to Upexi shareholders basic (2.87) (4.03) (5.92) (7.64) (23.03) (18.94)
Diluted income (loss) per share:            
Income (loss) per share from continuing operations diluted (2.87) (4.19) (5.92) (8.75) (24.60) (15.56)
(Loss) income per share from discontinued operations diluted 0 0.26 0 0.89 1.13 (1.53)
Total income (loss) per share attributable to Upexi shareholders diluted $ (2.87) $ (4.03) $ (5.92) $ (7.64) $ (23.03) $ (18.94)
Basic weighted average shares outstanding 1,336,373 1,021,210 1,140,995 1,036,182 1,027,232 893,943
Fully diluted weighted average shares outstanding 1,336,373 1,021,210 1,140,995 1,036,182 1,027,232 893,943